Related Experiment Video
Updated: Jun 30, 2026

07:16
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Biofilm formation by Pneumocystis spp
Melanie T Cushion1, Margaret S Collins, Michael J Linke
1University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML 560, Cincinnati, OH 45267-0560, USA. Melanie.Cushion@uc.edu
Eukaryotic Cell
|September 30, 2008
Summary
Researchers developed an in vitro biofilm model for Pneumocystis, a fungus causing pneumonia in immunocompromised individuals. This breakthrough allows studying fungal growth, spread, and survival strategies within the lungs.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Microbial Pathogenesis
Background:
- Pneumocystis spp. cause lethal pneumonia in immunocompromised hosts.
- Understanding Pneumocystis lung infection, spread, and survival is limited by the lack of continuous cultivation methods.
- Microbial biofilms offer protection, facilitate communication, and serve as dissemination foci.
Purpose of the Study:
- To investigate if Pneumocystis attachment and growth in lung alveoli resemble biofilm formation.
- To establish a tractable in vitro system for studying Pneumocystis.
Main Methods:
- An in vitro system using insert wells in supplemented RPMI 1640 medium was employed.
- Pneumocystis carinii (rat) and P. murina (mouse) were cultured to observe biofilm development.
- Confocal microscopy, antibody staining, and glucan content analysis were used to characterize biofilms.
Main Results:
- A stable in vitro biofilm model for Pneumocystis was successfully established.
- Organisms exhibited dramatic morphological changes, forming macroscopic clusters within an extracellular matrix.
- Passaged biofilms retained infectivity in immunosuppressed rodents.
- Farnesol inhibited biofilm formation, suggesting quorum sensing.
Conclusions:
- Pneumocystis forms biofilms in vitro, mimicking aspects of lung infection.
- This novel biofilm model provides a crucial tool for advancing Pneumocystis research.
- The findings open new avenues for understanding Pneumocystis pathogenesis and developing therapeutic strategies.
Related Concept Videos
Biofilms
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:

